Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Müller

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Journal of Clinical Psychopharmacology|August 13, 2002
How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depressionTom Bschor, Anne Berghöfer, Andreas Ströhle, et al.
Clinical Pharmacology and Therapeutics|October 19, 2002
The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatmentJürgen Brockmöller, Julia Kirchheiner, Jürgen Schmider, et al.
Journal of Affective Disorders|June 14, 2002
Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disordersMichael Bauer, Hiltrud Baur, Anne Berghöfer, et al.
Journal of Affective Disorders|March 17, 2004
Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-upChristopher Baethge, Philipp Gruschka, Anne Berghöfer, et al.
Journal of Psychiatry & Neuroscience : JPN|October 1, 2003
Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorderChristopher Baethge, Philipp Gruschka, Michael N Smolka, et al.
Development (Cambridge, England)|November 7, 2013
Theoretical and experimental evidence indicates that there is no detectable auxin gradient in the angiosperm female gametophyteDmytro S Lituiev, Nádia G Krohn, Bruno Müller, et al.
American Journal of Medical Genetics|March 29, 2002
Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporterRolf Kaiser, Bruno Müller-Oerlinghausen, Diana Filler, et al.
The Journal of Clinical Psychiatry|October 5, 2002
Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: results of a 2-year observational algorithm studyMazda Adli, Anne Berghöfer, Michael Linden, et al.
Depression and Anxiety|February 11, 2003
Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depressionTom Bschor, Christopher Baethge, Mazda Adli, et al.
BMC Plant Biology|February 18, 2025
Genome-wide characterization of two-component system elements in barley enables the identification of grain-specific phosphorelay genesChristian W Hertig, Pravinya Devunuri, Twan Rutten, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Journal of Clinical Psychopharmacology|August 13, 2002
How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depressionTom Bschor, Anne Berghöfer, Andreas Ströhle, et al.
Clinical Pharmacology and Therapeutics|October 19, 2002
The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatmentJürgen Brockmöller, Julia Kirchheiner, Jürgen Schmider, et al.
Journal of Affective Disorders|June 14, 2002
Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disordersMichael Bauer, Hiltrud Baur, Anne Berghöfer, et al.
Journal of Affective Disorders|March 17, 2004
Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-upChristopher Baethge, Philipp Gruschka, Anne Berghöfer, et al.
Journal of Psychiatry & Neuroscience : JPN|October 1, 2003
Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorderChristopher Baethge, Philipp Gruschka, Michael N Smolka, et al.
Development (Cambridge, England)|November 7, 2013
Theoretical and experimental evidence indicates that there is no detectable auxin gradient in the angiosperm female gametophyteDmytro S Lituiev, Nádia G Krohn, Bruno Müller, et al.
American Journal of Medical Genetics|March 29, 2002
Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporterRolf Kaiser, Bruno Müller-Oerlinghausen, Diana Filler, et al.
The Journal of Clinical Psychiatry|October 5, 2002
Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: results of a 2-year observational algorithm studyMazda Adli, Anne Berghöfer, Michael Linden, et al.
Depression and Anxiety|February 11, 2003
Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depressionTom Bschor, Christopher Baethge, Mazda Adli, et al.
BMC Plant Biology|February 18, 2025
Genome-wide characterization of two-component system elements in barley enables the identification of grain-specific phosphorelay genesChristian W Hertig, Pravinya Devunuri, Twan Rutten, et al.
Pageof 10